[Tickers Inside] 7 Solid Gainers Over the Last 5 Sessions

Stocks with 5 days of consecutive price advances. If you cannot see this email properly, please click [here]( --------------------------------------------------------------- Sponsor Message [The Lithium "Lie"]( [Find Out How Investors Can Benefit From the Energy War with China]( --------------------------------------------------------------- December 16, 2022 From the desk of the Editor (5 Day Gainers Report) Dear Reader, We just identified 7 Five Day Gainers across all US Exchanges. If you are interested in any of these companies, we encourage you to do your own research and due diligence. Keep reading to see what we just uncovered... --------------------------------------------------------------- Sponsor Message [Military Defense Impacted by Domestic Uranium Shortage?]( people know that the U.S. military's nuclear fleet is the largest uranium fuel consumer in the world. About 160 U.S. ships are powered by over 200 small nuclear reactors. While most are submarines, some icebreakers and aircraft carriers are also nuclear-powered. Unfortunately, current U.S. reliance on Russian state-owned sources for our uranium supply leaves our entire nuclear energy sector - including defense - vulnerable to geopolitical conflict such as Russia's war against Ukraine. [See the Factors Creating New Uranium Investment Opportunities]( --------------------------------------------------------------- [Neovasc, NVCN]( Recent Analyst Action: Vernon Bernardino, analyst at H.C. Wainwright, reiterates coverage on [Neovasc (NVCN)](in the Healthcare sector with a Buy rating and a price target of $20.00 (1 month ago). - Recent Price: $10.11 - Average Analyst Price Target: $20.00 (97.82%) - Market Cap: $27.49M [TipRanks.com]( also reports that [Neovasc](currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $20.00. The target pricing ranges from a high forecast of $20.00 down to a low forecast of $20.00. [Neovasc (NVCN)](’s last closing price was $10.11 which would put the average price target at $20.00. Here are 3rd party ratings for [NVCN](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Buy, Top 39% (96 out of 248) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecast: ["Prepare for Five Years of Famine"]( [Click here]( for the name of the one ticker you need to protect yourself. --------------------------------------------------------------- [Mammoth Energy Services, TUSK]( Recent Analyst Action: Unknown Analyst, analyst at Singular, reiterates coverage on [Mammoth Energy Services (TUSK)](in the Industrial Goods sector with a Buy rating and a price target of $10.5 (1 week ago). - Recent Price: $6.68 - Average Analyst Price Target: $10.50 (57.19%) - Market Cap: $300.91M [TipRanks.com]( also reports that [Mammoth Energy Services](currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $10.50. The target pricing ranges from a high forecast of $10.50 down to a low forecast of $10.50. [Mammoth Energy Services (TUSK)](’s last closing price was $6.68 which would put the average price target at $10.50. Here are 3rd party ratings for [TUSK](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: n/a, n/a [Click here for chart >>]( -------------------------------------------------------------------------- [Biomea Fusion, BMEA]( Recent Analyst Action: Joseph Pantginis, analyst at H.C. Wainwright, reiterates coverage on [Biomea Fusion (BMEA)](in the Healthcare sector with a Buy rating and a price target of $37.00 (11 hours ago). - Recent Price: $7.53 - Average Analyst Price Target: $26.00 (245.29%) - Market Cap: $215.18M [TipRanks.com]( also reports that [Biomea Fusion](currently has 3 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $26.00. The target pricing ranges from a high forecast of $37.00 down to a low forecast of $19.00. [Biomea Fusion (BMEA)](’s last closing price was $7.53 which would put the average price target at $26.00. Here are 3rd party ratings for [BMEA](: - TipRanks.com: Strong Buy - TradingView.com: Neutral - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: sell - Zacks.com: Hold, Top 24% (59 out of 248) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [The Best Deal In the History of Investing Research]( Street insiders, billionaires, and CEOs have paid us $103 MILLION to access our investing expertise... [but you can get access today for $1!]( --------------------------------------------------------------- [Willdan Group, WLDN]( Recent Analyst Action: Chip Moore, analyst at EF Hutton, reiterates coverage on [Willdan Group (WLDN)](in the Services sector with a Buy rating and a price target of $24.00 (1 month ago). - Recent Price: $17.6 - Average Analyst Price Target: $20.00 (13.64%) - Market Cap: $221.36M [TipRanks.com]( also reports that [Willdan Group](currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $20.00. The target pricing ranges from a high forecast of $24.00 down to a low forecast of $16.00. [Willdan Group (WLDN)](’s last closing price was $17.6 which would put the average price target at $20.00. Here are 3rd party ratings for [WLDN](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: sell - Zacks.com: Hold, Top 24% (59 out of 248) [Click here for chart >>]( -------------------------------------------------------------------------- [Esperion, ESPR]( Recent Analyst Action: Serge Belanger, analyst at Needham, reiterates coverage on [Esperion (ESPR)](in the Healthcare sector with a Buy rating and a price target of $12.00 (1 week ago). - Recent Price: $6.07 - Average Analyst Price Target: $13.00 (114.17%) - Market Cap: $428.84M [TipRanks.com]( also reports that [Esperion](currently has 5 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $13.00. The target pricing ranges from a high forecast of $22.00 down to a low forecast of $8.00. [Esperion (ESPR)](’s last closing price was $6.07 which would put the average price target at $13.00. Here are 3rd party ratings for [ESPR](: - TipRanks.com: Moderate Buy - TradingView.com: Sell - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: Buy, Top 37% (91 out of 248) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [More, More, More - Nuclear Energy, That Is...]( "perfect storm" of factors is breathing new life into the nuclear energy sector. The U.S. is working hard to build more advanced nuclear plants to achieve clean energy and climate goals. However, America's reliance on Russia for uranium has grave implications for national security. Fortunately, billions of dollars in Govt. incentives are now up for grabs to help revive the domestic uranium industry. [See How Investors Could Benefit From the Nuclear "Renaissance"]( --------------------------------------------------------------- [Sally Beauty, SBH]( Recent Analyst Action: Korinne Wolfmeyer, analyst at Piper Sandler, reiterates coverage on [Sally Beauty (SBH)](in the Consumer Goods sector with a Buy rating and a price target of $15.00 (1 day ago). - Recent Price: $12.785 - Average Analyst Price Target: $13.17 (3.01%) - Market Cap: $1.31B [TipRanks.com]( also reports that [Sally Beauty](currently has 3 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $13.17. The target pricing ranges from a high forecast of $15.00 down to a low forecast of $11.50. [Sally Beauty (SBH)](’s last closing price was $12.785 which would put the average price target at $13.17. Here are 3rd party ratings for [SBH](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: sell - Zacks.com: Sell, Top 35% (88 out of 248) [Click here for chart >>]( -------------------------------------------------------------------------- [Krystal Biotech, KRYS]( Recent Analyst Action: Raju Prasad, analyst at William Blair, reiterates coverage on [Krystal Biotech (KRYS)](in the Healthcare sector with a Buy rating (1 week ago). - Recent Price: $79.41 - Average Analyst Price Target: $110.33 (38.94%) - Market Cap: $2.00B [TipRanks.com]( also reports that [Krystal Biotech](currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $110.33. The target pricing ranges from a high forecast of $133.00 down to a low forecast of $79.00. [Krystal Biotech (KRYS)](’s last closing price was $79.41 which would put the average price target at $110.33. Here are 3rd party ratings for [KRYS](: - TipRanks.com: Strong Buy - TradingView.com: Strong Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Top 24% (59 out of 248) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Elon Musk and Bill Gates Agree On Nuclear Energy?]( Elon Musk to Bill Gates to politicians on both sides of the aisle, powerful people are now backing the expanded use of nuclear energy. They believe that safe, advanced nuclear technologies will play a vital role in our clean energy transition. Unfortunately, we're far too dependent on Russia for our uranium supply. That's why we desperately need more DOMESTIC sources of the yellow metal that fuels nuclear reactors. [See Why Uranium Should Now Be On Every Investor's Radar]( --------------------------------------------------------------- And there you have it--7 Five Day Gainers across all US Exchanges. Sincerely, The Editor, MarketTickerPress.com Market Ticker Press Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. By opening and/or clicking a link containted within this email, you are reconfirming your opt-in status. You can unsubscribe at any time. MarketTickerPress.com part of Sandpiper Marketing Group | 1519 Mecklenburg Hwy | Unit 4 | Mt. Mourne | North Carolina | 28123 | United States | 877-411-9808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software